U-M has 14 top 10 medical education programs in latest Doximity Residency Navigator

July 22, 2024 1:00 PM

Text reading "20+ Top-Ranked Residency Programs" next to an image of Michigan Medicine buildings

The University of Michigan Medical School has 14 top 10 residency programs, according to the 2024-25 Doximity Residency Navigator. Michigan boasts an additional nine programs that rank within the top 25.

U-M’s surgery residency ranked No. 1 out of 358 programs nationwide. Otolaryngology, pathology, plastic surgery, and urology all ranked No. 3 in their respective specialties.

Other top 10 programs at Michigan include medicine-pediatrics (ranked No. 5), nuclear medicine (6), anesthesiology (7), internal medicine (7), ophthalmology (7), radiation oncology (7), neurology (8), obstetrics & gynecology (8), and neurological surgery (10).

Also ranking in the top 25 in their specialties were dermatology (11), radiology (11), child neurology (13), physical medicine & rehabilitation (13), emergency medicine (14), family medicine (17), pediatrics (18), psychiatry (19), and orthopaedic surgery (24).

“Our programs’ rankings in the Doximity Residency Navigator reflect our continuing commitment to excellence in graduate medical education,” said J. Sybil Biermann, M.D., associate dean for graduate medical education at the U-M Medical School. “All of our ranked specialties placed in the top 25 with six in the top 5. Prospective residents can see that no matter their focus, Michigan has programs that rate among the nation’s best.”

Doximity’s Residency Navigator is a tool for medical students making residency decisions. It compiles ratings and reviews from current residents and alumni. Prospective residents can search for programs by a variety of criteria and build personalized lists. Doximity also collects data to create a reputation score for each school in each program, which are the basis for these rankings.

Satisfaction data is derived from satisfaction survey responses from each residency’s current residents and recent graduates, while reputation data is derived from nomination survey responses. This portion is limited to board-certified physicians in that specialty and is alumni weighted. Objective data is compiled from a variety of public sources, including the Doximity database, which covers all U.S. physicians.

For more information about the residency programs at U-M Medical School, visit medschool.umich.edu/programs-admissions/residency-fellowship.

To learn more about Doximity’s Residency Navigator results, visit doximity.com/residency.

Featured News & Stories

Doximity and U-M Medical School logos with text reading "20+ Top-Ranked Residency Programs" next to a photo of U-M buildings.

News Release

Seven U-M residency programs make national top 5 for their specialties

Twenty-four University of Michigan Health residency programs ranked within the top 25 for their specialties in the 2025-26 Doximity Residency Navigator.

UMich Med Mosaic

Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.

Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.

Portrait of Thomas Macek. He's wearing a navy blazer and light blue button-down shirt.

Philanthropy News

College of Pharmacy alum advances U-M Medical School addiction research

Grateful for support that help launched his career in pharmacology research and drug development, Tom Macek, Ph.D., has made a gift to the University of Michigan Medical School to advance addiction research.

Well-Being at Michigan Medicine

Rethinking care: How ‘de-implementation’ can improve quality and reduce burnout

In this episode of Well-Being at Michigan Medicine with Dr. Elizabeth Harry, Dr. Eve Kerr explores the concept of de-implementation—scaling back unnecessary tests, treatments, and administrative hurdles. Kerr shares how eliminating low-value practices can reduce clinician overload, lower patient costs, and improve overall health outcomes. Discover how both healthcare organizations and local frontline teams can foster a culture of high-value care by eliminating outdated processes.

Michigan Medicine Presents

Michigan Medicine Presents: Tommy Wang, M.D., Dean, University of Michigan Medical School

Join MD student Cassie Evans and PhD student Sam Collie for a wide-ranging conversation with Dean Tommy Wang, M.D. As he reflects on his journey to medicine and academic leadership, Dr. Wang shares his perspectives on student well-being, artificial intelligence, education, research and patient care through the lens of his new role as dean of the University of Michigan Medical School.